These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7815273)

  • 1. Kinetics of bromocriptine release from microspheres: comparative analysis between different in vitro models.
    Nastruzzi C; Esposito E; Cortesi R; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(5):565-74. PubMed ID: 7815273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE
    J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
    Preda M; Leucuta SE
    J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of PLG microspheres for tailored drug release.
    Berchane NS; Jebrail FF; Andrews MJ
    Int J Pharm; 2010 Jan; 383(1-2):81-8. PubMed ID: 19748560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic modeling on drug release from controlled drug delivery systems.
    Dash S; Murthy PN; Nath L; Chowdhury P
    Acta Pol Pharm; 2010; 67(3):217-23. PubMed ID: 20524422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release from ion-exchange microspheres: mathematical modeling and experimental verification.
    Abdekhodaie MJ; Wu XY
    Biomaterials; 2008 Apr; 29(11):1654-63. PubMed ID: 18192000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols.
    Salama RO; Traini D; Chan HK; Young PM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):145-52. PubMed ID: 18534832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliable targeting of specific drug release profiles by integrating arrays of different albumin-encapsulated microsphere types.
    Lee W; Wiseman ME; Cho NJ; Glenn JS; Frank CW
    Biomaterials; 2009 Dec; 30(34):6648-54. PubMed ID: 19775742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of cumulative release of valproic acid and vitamin E from hexadecanol microspheres. Part 2: Antiepileptic agents.
    Giannola LI; De Caro V; Di Stefano V; Rizzo MC
    Pharmazie; 1993 Dec; 48(12):917-20. PubMed ID: 8115437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
    Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
    J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to achieve sustained and complete protein release from PLGA-based microparticles?
    Giteau A; Venier-Julienne MC; Aubert-Pouëssel A; Benoit JP
    Int J Pharm; 2008 Feb; 350(1-2):14-26. PubMed ID: 18162341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-based microspheres as tools for drug delivery: a comparative study.
    Esposito E; Menegatti E; Cortesi R
    Int J Pharm; 2005 Jan; 288(1):35-49. PubMed ID: 15607256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on oral sustained-release microspheres of nifedipine].
    Fu CD; Jiang XT; Hu JH; Wu W
    Yao Xue Xue Bao; 1996; 31(9):706-11. PubMed ID: 9863236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres.
    Govender S; Pillay V; Chetty DJ; Essack SY; Dangor CM; Govender T
    Int J Pharm; 2005 Dec; 306(1-2):24-40. PubMed ID: 16246512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.